NasdaqHealth CarePharmaceutical PreparationsZUG, Switzerland

Oculis Holding AG OCS

Ask your AI

Estimated market cap $443.00M57.98M shares, shares as of Dec 31, 2025CIK 1953530

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

13 added · 8 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

What changed in Oculis Holding AG's latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No recent insider purchases or sales for this company.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

15.47M shares

38 funds report OCS. Values checked against market prices.

Funds own 40% of shares (Q2 2026)

60 funds hold the stock.

Q3 2026: 27% · 5,560 of ~8,900 funds reported so far

Q2 20258.8%
Q3 202519%
Q4 202531%
Q1 202635%
Q2 202640%
Q3 2026 (so far)27%

Q3 2026. 10 new, 13 added to, 8 trimmed, 33 exited since Q2 2026.

Top 13F holders
#
1	EQT Fund Management S.a r.l. 13F ↗	6.95M	$64.9M	unchanged
2	Aberdeen Group plc 13F ↗	2.28M	$21.3M	+5.5%
3	Pivotal bioVenture Partners Investment Advisor LLC 13F ↗	1.66M	$15.5M	+10.1%
4	Franklin Templeton Inc 13F ↗	897,164	$6.5M	+106.4%
5	Siren, LLC 13F ↗	625,000	$5.8M	unchanged
6	Qube Research & Technologies Ltd 13F ↗	470,647	$4.4M	+79.6%
7	Manufacturers Life Insurance Company, the 13F ↗	398,701	$3.7M	-0.1%
8	Syquant Capital SAS 13F ↗	375,000	$2.8M	unchanged
9	Nan Fung Group Holdings Ltd 13F ↗	300,565	$2.8M	unchanged
10	Marshall Wace, LLP 13F ↗	262,922	$2.5M	-33.4%

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds OCS, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Oculis Holding AG and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Oculis Holding AG and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2023	7	—	3.12M	$23.2M
Q2 2023	9	+2	3.13M	$38.5M
Q3 2023	9	0	2.92M	$32.1M
Q4 2023	7	-2	3.98M	$44.3M
Q1 2024	9	+2	3.39M	$40.9M
Q2 2024	11	+2	3.33M	$39.8M
Q3 2024	10	-1	3.01M	$36.9M
Q4 2024	12	+2	3.49M	$59.4M
Q1 2025	20	+8	4.98M	$94.7M
Q2 2025	23	+3	5.11M	$99.1M
Q3 2025	20	-3	10.89M	$191.7M
Q4 2025	41	+21	18.08M	$363.8M
Q1 2026	57	+16	20.12M	$534.7M
Q2 2026	60	+3	23.31M	$323.3M
Q3 2026	38	-22	15.47M	$141.9M

Each point is a quarter-end, from Q1 2023 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (H5870P102). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2023) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes2 in 12 mo 8-K eventsNone in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 1 in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials2 active IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Oculis Holding AG
Address: BAHNHOFSTRASSE 7, ZUG, Switzerland 6300
Phone: 617-937-2423
Fiscal year ends: Dec 31
Filer category: Large accelerated filer
Incorporated in: Switzerland
Listed as: OCS (Nasdaq), OCSAW (Nasdaq)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$7.64+$0.14 (+1.87%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $6.83 · High $8.26Nov 13, 2026

Aug 13, 2026Low $6.83 · High $13.57Nov 13, 2026

Nov 13, 2025Low $6.83 · High $32.65Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.